Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures

Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, Hideo Matsumoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We report the 5-year follow-up of a young woman who developed vertebral fractures after pregnancy and lactation and was treated with active vitamin D hormone. A 32-year-old Japanese woman consulted us because of acute lower back pain caused by L2 and L5 vertebral fractures after pregnancy and lactation. Following cessation of breast-feeding, analgesia, bed rest, and wearing of a hard brace, her lower back pain disappeared within 2 months. After 5 years of treatment with alfacalcidol 1 μg daily, the lumbar spine (L1, L3, L4) bone mineral density increased by 21.4% following vigorous reductions in bone turnover markers. No osteoporotic fractures occurred, and the vertebral fractures healed. The patient experienced no side effects, including hypercalcemia. Thus, the present case report shows long-term changes in bone turnover markers and lumbar spine bone mineral density, as well as long-term safety of alfacalcidol treatment in a young woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.

Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalTherapeutics and Clinical Risk Management
Volume8
DOIs
Publication statusPublished - 2012

Fingerprint

bone disease
Lactation
Osteoporosis
pregnancy
Bone Remodeling
Low Back Pain
Bone
turnover
Pregnancy
Bone Density
pain
Spine
Bed Rest
Braces
Osteoporotic Fractures
Hypercalcemia
Minerals
Breast Feeding
Vitamin D
Analgesia

Keywords

  • Alfacalcidol
  • Bone mineral density
  • Osteoporosis
  • Pregnancy
  • Vertebral fracture
  • Young woman

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Safety Research
  • Chemical Health and Safety

Cite this

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures. / Iwamoto, Jun; Sato, Yoshihiro; Uzawa, Mitsuyoshi; Matsumoto, Hideo.

In: Therapeutics and Clinical Risk Management, Vol. 8, 2012, p. 195-199.

Research output: Contribution to journalArticle

Iwamoto, Jun ; Sato, Yoshihiro ; Uzawa, Mitsuyoshi ; Matsumoto, Hideo. / Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures. In: Therapeutics and Clinical Risk Management. 2012 ; Vol. 8. pp. 195-199.
@article{a4f48f00bc9c4547b7e19892e7a5a1c5,
title = "Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures",
abstract = "We report the 5-year follow-up of a young woman who developed vertebral fractures after pregnancy and lactation and was treated with active vitamin D hormone. A 32-year-old Japanese woman consulted us because of acute lower back pain caused by L2 and L5 vertebral fractures after pregnancy and lactation. Following cessation of breast-feeding, analgesia, bed rest, and wearing of a hard brace, her lower back pain disappeared within 2 months. After 5 years of treatment with alfacalcidol 1 μg daily, the lumbar spine (L1, L3, L4) bone mineral density increased by 21.4{\%} following vigorous reductions in bone turnover markers. No osteoporotic fractures occurred, and the vertebral fractures healed. The patient experienced no side effects, including hypercalcemia. Thus, the present case report shows long-term changes in bone turnover markers and lumbar spine bone mineral density, as well as long-term safety of alfacalcidol treatment in a young woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.",
keywords = "Alfacalcidol, Bone mineral density, Osteoporosis, Pregnancy, Vertebral fracture, Young woman",
author = "Jun Iwamoto and Yoshihiro Sato and Mitsuyoshi Uzawa and Hideo Matsumoto",
year = "2012",
doi = "10.2147/TCRM.S30668",
language = "English",
volume = "8",
pages = "195--199",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures

AU - Iwamoto, Jun

AU - Sato, Yoshihiro

AU - Uzawa, Mitsuyoshi

AU - Matsumoto, Hideo

PY - 2012

Y1 - 2012

N2 - We report the 5-year follow-up of a young woman who developed vertebral fractures after pregnancy and lactation and was treated with active vitamin D hormone. A 32-year-old Japanese woman consulted us because of acute lower back pain caused by L2 and L5 vertebral fractures after pregnancy and lactation. Following cessation of breast-feeding, analgesia, bed rest, and wearing of a hard brace, her lower back pain disappeared within 2 months. After 5 years of treatment with alfacalcidol 1 μg daily, the lumbar spine (L1, L3, L4) bone mineral density increased by 21.4% following vigorous reductions in bone turnover markers. No osteoporotic fractures occurred, and the vertebral fractures healed. The patient experienced no side effects, including hypercalcemia. Thus, the present case report shows long-term changes in bone turnover markers and lumbar spine bone mineral density, as well as long-term safety of alfacalcidol treatment in a young woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.

AB - We report the 5-year follow-up of a young woman who developed vertebral fractures after pregnancy and lactation and was treated with active vitamin D hormone. A 32-year-old Japanese woman consulted us because of acute lower back pain caused by L2 and L5 vertebral fractures after pregnancy and lactation. Following cessation of breast-feeding, analgesia, bed rest, and wearing of a hard brace, her lower back pain disappeared within 2 months. After 5 years of treatment with alfacalcidol 1 μg daily, the lumbar spine (L1, L3, L4) bone mineral density increased by 21.4% following vigorous reductions in bone turnover markers. No osteoporotic fractures occurred, and the vertebral fractures healed. The patient experienced no side effects, including hypercalcemia. Thus, the present case report shows long-term changes in bone turnover markers and lumbar spine bone mineral density, as well as long-term safety of alfacalcidol treatment in a young woman with pregnancy and lactation-associated osteoporosis and vertebral fractures.

KW - Alfacalcidol

KW - Bone mineral density

KW - Osteoporosis

KW - Pregnancy

KW - Vertebral fracture

KW - Young woman

UR - http://www.scopus.com/inward/record.url?scp=84875314848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875314848&partnerID=8YFLogxK

U2 - 10.2147/TCRM.S30668

DO - 10.2147/TCRM.S30668

M3 - Article

C2 - 22547939

AN - SCOPUS:84875314848

VL - 8

SP - 195

EP - 199

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

ER -